Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the effects of CLP, with and without spironolactone, on serum, urine, and fecal contents in heart failure patients with chronic kidney disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sorbent Therapeutics
NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure
NCT03103932 · Heart Failure; With Decompensation
NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more
NCT04347655 · Heart Failure
NCT06307652 · Heart Failure and Impaired Kidney Function
Orange Country Research Center
Tustin, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions